Search Results - "Emelin, A Yu"

Refine Results
  1. 1

    The possibilities of diagnosing and treating cognitive impairment at non-dementia stages by Emelin, A. Yu

    “…At the present stage of development of medicine and society, there is no doubt that early detection and treatment of nervous system diseases accompanied by…”
    Get full text
    Journal Article
  2. 2

    Possibilities of combined use of peptides in the treatment of post-stroke asthenia by Emelin, A. Yu, Lobzin, V. Yu

    “…Among the various syndromes in the post-stroke period, asthenic disorder plays an important role, the presence of which is associated with unfavourable course…”
    Get full text
    Journal Article
  3. 3

    Evaluation of the therapeutic efficacy of the drug Cytochrome C in the treatment of asthenia in outpatients (CITRIN study) by Lobzin, V. Yu, Emelin, A. Yu, Kolmakova, K. A.

    “…Asthenic syndrome occurs in most chronic diseases, and doctors encounter it in outpatient appointments for both somatic and neurological pathologies. Drugs…”
    Get full text
    Journal Article
  4. 4

    Comorbidity of cerebral amyloid angiopathy and Alzheimer's disease. Clinical case analysis by Emelin, A. Yu, Lobzin, V. Yu, Efimtsev, A. Yu, Vorobyov, S. V.

    “…The development of cognitive impairment in old age is often caused by overlapping neurodegenerative and cerebrovascular changes which have a mutually…”
    Get full text
    Journal Article
  5. 5

    Complex Differential Diagnosis of Cognitive Impairments by Emelin, A. Yu, Lobzin, V. Yu

    Published in Neuroscience and behavioral physiology (15-05-2019)
    “…This article addresses different aspects of the predementia stage of cognitive disorders of mainly neurodegenerative genesis. Current views of the…”
    Get full text
    Journal Article
  6. 6

    Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises by Emelin, A. Yu, Lobzin, V. Yu

    “…To manage patients with vascular cognitive impairment (VCI) is an extremely difficult task, since drug therapy algorithms have not been elaborated, whereas the…”
    Get full text
    Journal Article
  7. 7

    Depression and dementia: differentiation and comorbidity by Lobzin, V. Yu, Emelin, A. Yu

    “…The relationship between cognitive impairment (CI) and depression is complicated: h\the latter can be one of the symptoms of Alzheimer’s disease or may precede…”
    Get full text
    Journal Article
  8. 8

    Therapy of poststroke cognitive impairment by A. Yu. Emelin

    Published in Medicinskij sovet (01-12-2016)
    “…The main issues of poststroke cognitive impairment’s etiology and pathogenesis are considered in this article. Historical stages of the poststroke dementia…”
    Get full text
    Journal Article
  9. 9

    Errors in the management of patients with Alzheimer's disease: analysis of problems and ways of their solution by Emelin, A. Yu, Litvinenko, I. V., Lobzin, V. Yu

    “…Epidemiological data show that Alzheimer's disease (AD) is the most common cause of acquired cognitive impairment (CI). At the same time, according to…”
    Get full text
    Journal Article
  10. 10

    Cognitive impairments in cerebrovascular disease: What is between health and dementia? by Emelin, A. Yu

    “…The problem of cerebrovascular lesions takes on even greater significance with the higher prevalence of both acute and chronic forms of cerebrovascular…”
    Get full text
    Journal Article
  11. 11

    Cognitive impairments in cerebrovascular disease by Emelin, A. Yu

    “…Cerebrovascular diseases belong to a group of the major causes of cognitive impairments, in the elderly in particular. The paper presents current ideas on the…”
    Get full text
    Journal Article
  12. 12

    Prospects for the use of graphene-based biological sensors in the early diagnosis of Alzheimer's disease (review of literature) by Vorobev, S V, Yanishevskij, S N, Emelin, A Yu, Lebedev, A A, Lebedev, S P, Makarov, Yu N, Usikov, A S, Klotchenko, S A, Vasin, A V

    Published in Klinicheskaia laboratornaia diagnostika (21-01-2022)
    “…Among the most significant challenges presented to modern medicine is the problem of cognitive disorders. The relevance of her research is determined by the…”
    Get more information
    Journal Article
  13. 13

    A novel view on Alzheimer’s disease pathogenesis: modern conceptof amyloid clearance by Lobzin, V. Yu, Kolmakova, K. A., Emelin, A. Yu

    “…Alzheimer’s disease is the most common cause of dementia among the elderly. Te pathological changes characterize by the deposition of amyloid plaques and the…”
    Get full text
    Journal Article
  14. 14

    Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment by Litvinenko, I. V., Emelin, A. Yu, Lobzin, V. Yu, Kolmakova, K. A.

    “…The paper provides data on current neuroimaging techniques for diagnosing Alzheimer’s disease and vascular cognitive impairment (CN). Structural neuroimaging…”
    Get full text
    Journal Article
  15. 15

    Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial) by Litvinenko, I. V., Odinak, M. M., Mogil’naya, V. I., Emelin, A. Yu

    Published in Neuroscience and behavioral physiology (01-11-2008)
    “…An open controlled trial of the use of galantamine at a maximum dose of 16 mg/day included 41 patients with Parkinson's disease with dementia randomized to a…”
    Get full text
    Journal Article
  16. 16
  17. 17

    he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments by Litvinenko, I. V., Emelin, A. Yu, Lobzin, V. Yu, Kolmakova, K. A., Naumov, K. M., Lupanov, I. A., Kilivaeva, G. A., Alizade, M. R.

    “…In 1887, S.A. Belyakov, a physician of the Imperial Medical and Surgical Academy, first described amyloid deposits in the brain of patients with dementia…”
    Get full text
    Journal Article
  18. 18

    Correction of Subdementia Cognitive Impairments in Patients with Cerebral Ischemia by Odinak, M. M., Kashin, A. V., Emelin, A. Yu, Lupanov, I. A.

    Published in Neuroscience and behavioral physiology (01-10-2014)
    “…The most important of the causes of derangement of cognitive functions in elderly people are cerebrovascular diseases. Vascular cognitive impairments are not…”
    Get full text
    Journal Article
  19. 19

    Value of determining the cerebrospinal fluid protein markers of amyloidosis and neurodegeneration in the diagnosis of vascular and neurodegenerative cognitive impairments by Lobzin, Vladimir Yuryevich, Emelin, A Yu, Odinak, M M, Alekseeva, L A, Monakhova, N E

    “…The article presents data on different forms of moderate cognitive impairments (MCI) and the specific features of their transformation to dementia…”
    Get full text
    Journal Article
  20. 20